Stock Quote

Elan Corp PLC (ELN.N) (New York Stock Exchange)
As of  23 Nov 2009
6.35USD
Price Change
-0.11
Percent Change
-1.70%
 
$6.35
23 Nov 2009
-1.70%
$6.46
$6.49
509,200
$6.53
$6.31
$9.13
$4.61
0.87
4,204,401

Research Another Stock: Symbol Look-up
Elan, Biogen change Tysabri label due to PML risk
Saturday, 7 Nov 2009 10:34am EST 
J&J slashing workforce
Tuesday, 3 Nov 2009 02:41pm EST 
J&J to slash 7,000 to 8,000 jobs
Tuesday, 3 Nov 2009 02:06pm EST 
Thursday Options Recap
Thursday, 12 Nov 2009 04:18pm EST(Seeking Alpha) 
Cramer's Lightning Round - The Only Water Stock Worth Buying (11/10/09)
Wednesday, 11 Nov 2009 07:22am EST(Seeking Alpha) 
'Mad Money Lightning Round': Buy Bucyrus on Weakness
Tuesday, 10 Nov 2009 07:35pm EST(The Street) 
Nice Quarter, Teva. What Will You Buy Next?
Tuesday, 3 Nov 2009 10:31am EST(The Motley Fool) 
A Crazy October
Monday, 2 Nov 2009 04:23pm EST(Seeking Alpha) 
 
Name Current Position Compensation
McLaughlin, Kyran Non-Executive Chairman of the Board 300,000
Martin, G. Kelly Chief Executive Officer, Executive Director 830,496
Paya, Carlos President --

Profile

Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. Its principal research and development, manufacturing and marketing facilities are located in Ireland and the United States. Elan’s operations are organized into two business units: Biopharmaceuticals and Elan Drug... Full Description

Company Address

Elan Corp PLC
Treasury Building
Lower Grand Canal Street
Dublin     2
P: +3531.7094000
F: +3531.7094108

Analyst Research

  ELN.N Industry
P/E(TTM) -- 3.57
P/S(TTM) 4.76 0.57
ROI(TTM) -3.03 1.86
ROE(TTM) -- 2.51
Consensus Recommendation Outperform
EPS Est. (Current Period) 0.00
EPS Est. (Current Year) -0.40
Total Revenue $259.05M
Net Income $-111.34M
EPS $-0.23